CtheSigns vs GGPO Guidelines Usage & Stats

C the Signs is a multi-platform decision support tool for doctors that uses the latest evidence to help identify patients with Cancer at the earliest stages of the disease. The tool has the ability to simultaneously check combinations of signs, symptoms and risk factors, in an easy to use format. It can be used during the consultation, when the opportunity to influence decision-making is at its greatest. Features: - Covers the whole spectrum of cancer, from childhood to old age - Search by system (e.g. "chest" or "breast") - Search by symptom, sign or investigation result (e.g. "appetite loss" or "thrombocytosis") - Delivers recommendations on what test, investigation or referral should be made - Cross-references all symptoms against the entire database - Specifically designed to be fast, intuitive and deliver a result within 30 seconds We are regulated by the Medicines Healthcare and products Regulatory Agency (MHRA).
  • Apple App Store
  • Free
  • Medical

Store Rank

- -

Every evidence-based guideline of the German Guideline Program in Oncology (GGPO) in a single app. This app contains the complete contents of the GGPO guidelines, including tables, algorithms and literature references. Additional features: • Receive alerts as soon as guidelines are updated, or new guidelines are available. • Easy and convenient search within the guidelines, including filters for recommendations. • Save individual recommendations, tables or figures in your favorites. • Send comments concerning guidelines directly to the Guideline Program
  • Apple App Store
  • Free
  • Medical

Store Rank

- -

CtheSigns vs. GGPO Guidelines ranking comparison

Compare CtheSigns ranking trend in the past 28 days vs. GGPO Guidelines

Rank

No Data Available

CtheSigns vs. GGPO Guidelines ranking by country comparison

Compare CtheSigns ranking trend in the past 28 days vs. GGPO Guidelines

No Data to Display

Compare to any site with our free trial

Get started
CtheSigns VS.
GGPO Guidelines

January 17, 2025